1-((3,5-dimethyl-1H-pyrazol-4-yl)sulfonyl)piperazine hydrochloride, 95.0%, 250mg

Ethyl 2-(2-cyanophenyl)acetate, 95.0%, 1g

4-(4-Bromopyrimidin-2-yl)morpholine, 95.0%, 10g

Lithocholic acid, min. 98%, 10 g, glass packaging

1,4-Epoxycyclohexane>98.0%(GC)5mL

H-Glu(OBzl)-Obzl.TosOH, 95%, 25g

7-Chloro-2-methyl-1-heptene, 97.0%, 1g

(4-(Thiophen-2-yl)phenyl)boronic acid, 96%, 5g

6-Methylisoquinolin-1(2H)-one, 97%, 250mg

(1R*,4R*)-N1-(Tetrahydro-2H-pyran-4-yl)cyclohexane-1,4-diamine dihydrochloride, 1g

2-Bromo-5-fluoroisonicotinic acid, 95.0%, 1g

Ethyl 1-(4-methoxybenzyl)-1H-1,2,3-triazole-4-carboxylate, 99.0%, 1g

1-(4-fluorophenyl)-6-mercapto-1,5-dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-one, 95.0%, 250mg